Type 2 Diabetes: The Leading Cause Of Deadly Diseases

1635 Words7 Pages
BIOLOGY 114 2011 Type II Diabetes The leading cause of deadly diseases Donisha Brewer OUTLINE I. INTRODUCTION A. HYPOTHESIS B. BACK GROUND DATA II. ABSTRACT III. BODY A. WHO DOES TYPE II DIABETES AFFECT B. DIAGNOSIS C. SCREENING AND PREVENTION D. COMPLICATIONS E. TREATMENT IV. CONCLUSION V. SUMMARY VI. WORK CITIED INTRODUCTION Type 2 diabetes is the most common form of diabetes. Millions of Americans have been diagnosed with type 2 diabetes, and many more are unaware they are at high risk. Some groups have a higher risk for developing type II diabetes than others. Type 2 diabetes is more common in African Americans, Latinos, Native Americans, and as well as the aged…show more content…
Hispanic Americans may be 2 percent more likely than whites to get diabetes and African-Americans are about 4 percent more likely. The data are less clear for smaller minority groups, but in some Native American communities the rate of diabetes may be up to four times higher than in white communities. Not only are people in these groups more likely to develop type II diabetes, but they may have worse blood sugar control and more severe diabetes complications. For example, African-Americans with diabetes are between two and four times more likely than non-Hispanic whites to experience kidney problems, blindness, or amputation. Minorities are generally between two and four times more likely than non-Hispanic whites to die from…show more content…
Some of the complications are as follow: Heart attack and stroke occur 2 to 4 times more frequently in persons with diabetes than in those without the disease. Cardiovascular disease is the major cause of death in adults with diabetes. Inadequately controlled hypertension and dyslipidemia are 2 comorbidities that contribute to the development of coronary artery disease (CAD) and stroke. It is well recognized that lipid disorders and hypertension also occur in children with diabetes. Type 2 diabetes is an independent risk factor for CAD, hypertension, and dyslipidemia.] Therefore, aggressive management of adult patients with dyslipidemia is recommended. Treatment may include prescription of a hydroxymethylglutaryl co-enzyme a reductase inhibitor (statin), niacin, or fibrinate, alone or in combination with MNT, to achieve NCEP target goals. The main intervention for dyslipidemia in pediatric patients is MNT, coupled with efforts to achieve optimal glycemic control with sparing of lipid-lowering

More about Type 2 Diabetes: The Leading Cause Of Deadly Diseases

Open Document